SG Americas Securities
SBBP

SG Americas Securities’s Strongbridge Biopharma plc. SBBP Stock Holding History

SG Americas Securities’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,525
Closed -$74K – 3754
2020
Q2 		$74K Buy
19,525
+6,934
+55% +$20.8K ﹤0.01% 3461
2020
Q1 		$24K Buy
+12,591
New +$32.7K ﹤0.01% 3285
2018
Q1 		– Sell
-11,571
Closed -$84K – 3656
2017
Q4 		$84K Buy
+11,571
New +$72.3K ﹤0.01% 2898

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities's SBBP Position: Q3 2020 in Review

SG Americas Securities sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2020, closing a stake of 19,525 shares — an estimated $74K sold.

SG Americas Securities first reported a position in SBBP in Q4 2017 and held it in 3 quarters. The position peaked at $84K in Q4 2017. 77 funds tracked by Wall St. Rank hold SBBP as of Q3 2020.

  • SG Americas Securities reported no remaining Strongbridge Biopharma plc. position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 19,525 Strongbridge Biopharma plc. shares in Q3 2020, an estimated $74K.
  • SG Americas Securities first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 3 quarters.
  • SG Americas Securities's Strongbridge Biopharma plc. position peaked at $84K in Q4 2017.
  • 77 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.